
Astellas Pharma Inc
TSE:4503

Intrinsic Value
The intrinsic value of one
Astellas Pharma Inc
stock under the Base Case scenario is
1 825.88
JPY.
Compared to the current market price of 1 269.5 JPY,
Astellas Pharma Inc
is
Undervalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Astellas Pharma Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Astellas Pharma Inc
Balance Sheet Decomposition
Astellas Pharma Inc
Current Assets | 1.2T |
Cash & Short-Term Investments | 212.4B |
Receivables | 657.6B |
Other Current Assets | 334B |
Non-Current Assets | 2.2T |
Long-Term Investments | 144.8B |
PP&E | 332.7B |
Intangibles | 1.6T |
Other Non-Current Assets | 126.1B |
Free Cash Flow Analysis
Astellas Pharma Inc
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Astellas Pharma Inc
Revenue
|
1.9T
JPY
|
Cost of Revenue
|
-345.6B
JPY
|
Gross Profit
|
1.5T
JPY
|
Operating Expenses
|
-1.5T
JPY
|
Operating Income
|
-13.2B
JPY
|
Other Expenses
|
-44.3B
JPY
|
Net Income
|
-57.4B
JPY
|
Profitability Score
Profitability Due Diligence
Astellas Pharma Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Score
Astellas Pharma Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Astellas Pharma Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
Astellas Pharma Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Astellas Pharma Inc
According to Wall Street analysts, the average 1-year price target for
Astellas Pharma Inc
is 1 903.03 JPY
with a low forecast of 1 414 JPY and a high forecast of 2 520 JPY.
Dividends
Current shareholder yield for Astellas Pharma Inc is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Astellas Pharma Inc
stock under the Base Case scenario is
1 825.88
JPY.
Compared to the current market price of 1 269.5 JPY,
Astellas Pharma Inc
is
Undervalued by 30%.